Otros idiomas NeuroOne Medical Technologies Corporation Other OTC

Acciones

NMTC

US64130M1009

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

NeuroOne Medical Files Shelf Registration For $150 Million Securities Offering	31/05
NeuroOne Medical Technologies Corporation Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	14/05
NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update	14/05
NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14	10/05
NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology	10/04
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes	09/04
NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.	04/04
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System	26/03
NeuroOne Medical Technologies Corporation Initiates Limited Commercial Launch of OneRF Ablation System	26/03
NeuroOne to Participate in the 36th Annual Roth Conference	11/03
NeuroOne® to Participate in the 36th Annual Roth Conference	08/03
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)	23/02
NeuroOne Medical Technologies Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023	13/02
NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update	13/02
NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13	08/02
NeuroOne Medical Technologies Corporation Reports Earnings Results for the Full Year Ended September 30, 2023	14/12
NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update	14/12
NeuroOne Gets FDA Clearance to Market OneRF Ablation System; Shares Fall	11/12
NeuroOne Medical Technologies Corporation Receives FDA 510(K) Clearance to Market its OneRF(TM) Ablation System	11/12
NeuroOne® Receives FDA 510(k) Clearance to Market its OneRF™ Ablation System	11/12

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas NeuroOne Medical Technologies Corporation Other OTC

Acciones

NMTC

US64130M1009

Otros idiomas

Filtros